Not Tagged
Not Tagged
['lcsm,(-blcsm)']
 to summarise paper: we followed safety and hrqol. most aes within 1st 12 mo, aes leading to dose red 12%/interupt 27%/discontinuation 13% ( compared to 1/13/3% placebo). commonest cause discontinuation was ild, per protocol #lcsm #asco23 
Medical Oncologist, Translational Researcher, Peter Mac. Tweets are my own opinions. Musician (@mayhemtomi) https://t.co/f3ccD2MSX3